Cargando…

Trajectory of plasma syndecan‐1 and heparan sulphate during major surgery: A retrospective observational study

BACKGROUND: Surgical trauma‐induced inflammation during major surgery may disrupt endothelial integrity and affect plasma concentrations of glycocalyx constituents, such as syndecan‐1 and heparan sulphate. To date, no studies have focused on their perioperative temporal changes. METHODS: As part of...

Descripción completa

Detalles Bibliográficos
Autores principales: Weinberg, Laurence, Yanase, Fumitaka, Tosif, Shervin, Riedel, Bernhard, Bellomo, Rinaldo, Hahn, Robert G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087164/
https://www.ncbi.nlm.nih.gov/pubmed/36112130
http://dx.doi.org/10.1111/aas.14150
_version_ 1785022284266733568
author Weinberg, Laurence
Yanase, Fumitaka
Tosif, Shervin
Riedel, Bernhard
Bellomo, Rinaldo
Hahn, Robert G.
author_facet Weinberg, Laurence
Yanase, Fumitaka
Tosif, Shervin
Riedel, Bernhard
Bellomo, Rinaldo
Hahn, Robert G.
author_sort Weinberg, Laurence
collection PubMed
description BACKGROUND: Surgical trauma‐induced inflammation during major surgery may disrupt endothelial integrity and affect plasma concentrations of glycocalyx constituents, such as syndecan‐1 and heparan sulphate. To date, no studies have focused on their perioperative temporal changes. METHODS: As part of a trial, we obtained plasma and urine specimens sampled during the perioperative period in 72 patients undergoing major abdominal surgery. The plasma concentration of syndecan‐1 and heparan sulphate was measured on five occasions, from baseline to the second postoperative day. Plasma and urinary creatinine and urinary syndecan‐1 concentrations were measured before surgery and on the first postoperative morning. RESULTS: We observed three different temporal patterns of plasma syndecan‐1 concentration. Group 1 ‘low’ (64% of patients) showed only minor changes from baseline despite a median heparan sulphate increase of 67% (p < .005). Group 2 ‘increase’ (21% of patients) showed a marked increase in median plasma syndecan‐1 from 27 μg/L to 118 μg/L during the first postoperative day (p < .001) with a substantial (+670%; p < .005) increase in median plasma heparan sulphate from 279 to 2196 μg/L. Group 3 ‘high’ (14% of patients) showed a constant elevation of plasma syndecan‐1 to >100 μg/L, but low heparan sulphate levels. The plasma C‐reactive protein concentration did not differ across the three groups and 90% of colon surgeries occurred in Group 1. Treatment with dexamethasone was similar across the three groups. Surgical blood loss, duration of surgery and liver resection were greatest in Group 2. CONCLUSION: Changes in syndecan‐1 and heparan sulphate after surgery appear to show three different patterns, with the greatest increases in those patients with greater blood loss, more liver surgery and longer operations. These observations suggest that increases in syndecan‐1 and heparan sulphate reflect the degree of surgical injury.
format Online
Article
Text
id pubmed-10087164
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100871642023-04-12 Trajectory of plasma syndecan‐1 and heparan sulphate during major surgery: A retrospective observational study Weinberg, Laurence Yanase, Fumitaka Tosif, Shervin Riedel, Bernhard Bellomo, Rinaldo Hahn, Robert G. Acta Anaesthesiol Scand Research Articles BACKGROUND: Surgical trauma‐induced inflammation during major surgery may disrupt endothelial integrity and affect plasma concentrations of glycocalyx constituents, such as syndecan‐1 and heparan sulphate. To date, no studies have focused on their perioperative temporal changes. METHODS: As part of a trial, we obtained plasma and urine specimens sampled during the perioperative period in 72 patients undergoing major abdominal surgery. The plasma concentration of syndecan‐1 and heparan sulphate was measured on five occasions, from baseline to the second postoperative day. Plasma and urinary creatinine and urinary syndecan‐1 concentrations were measured before surgery and on the first postoperative morning. RESULTS: We observed three different temporal patterns of plasma syndecan‐1 concentration. Group 1 ‘low’ (64% of patients) showed only minor changes from baseline despite a median heparan sulphate increase of 67% (p < .005). Group 2 ‘increase’ (21% of patients) showed a marked increase in median plasma syndecan‐1 from 27 μg/L to 118 μg/L during the first postoperative day (p < .001) with a substantial (+670%; p < .005) increase in median plasma heparan sulphate from 279 to 2196 μg/L. Group 3 ‘high’ (14% of patients) showed a constant elevation of plasma syndecan‐1 to >100 μg/L, but low heparan sulphate levels. The plasma C‐reactive protein concentration did not differ across the three groups and 90% of colon surgeries occurred in Group 1. Treatment with dexamethasone was similar across the three groups. Surgical blood loss, duration of surgery and liver resection were greatest in Group 2. CONCLUSION: Changes in syndecan‐1 and heparan sulphate after surgery appear to show three different patterns, with the greatest increases in those patients with greater blood loss, more liver surgery and longer operations. These observations suggest that increases in syndecan‐1 and heparan sulphate reflect the degree of surgical injury. John Wiley and Sons Inc. 2022-09-27 2023-01 /pmc/articles/PMC10087164/ /pubmed/36112130 http://dx.doi.org/10.1111/aas.14150 Text en © 2022 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley & Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Weinberg, Laurence
Yanase, Fumitaka
Tosif, Shervin
Riedel, Bernhard
Bellomo, Rinaldo
Hahn, Robert G.
Trajectory of plasma syndecan‐1 and heparan sulphate during major surgery: A retrospective observational study
title Trajectory of plasma syndecan‐1 and heparan sulphate during major surgery: A retrospective observational study
title_full Trajectory of plasma syndecan‐1 and heparan sulphate during major surgery: A retrospective observational study
title_fullStr Trajectory of plasma syndecan‐1 and heparan sulphate during major surgery: A retrospective observational study
title_full_unstemmed Trajectory of plasma syndecan‐1 and heparan sulphate during major surgery: A retrospective observational study
title_short Trajectory of plasma syndecan‐1 and heparan sulphate during major surgery: A retrospective observational study
title_sort trajectory of plasma syndecan‐1 and heparan sulphate during major surgery: a retrospective observational study
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087164/
https://www.ncbi.nlm.nih.gov/pubmed/36112130
http://dx.doi.org/10.1111/aas.14150
work_keys_str_mv AT weinberglaurence trajectoryofplasmasyndecan1andheparansulphateduringmajorsurgeryaretrospectiveobservationalstudy
AT yanasefumitaka trajectoryofplasmasyndecan1andheparansulphateduringmajorsurgeryaretrospectiveobservationalstudy
AT tosifshervin trajectoryofplasmasyndecan1andheparansulphateduringmajorsurgeryaretrospectiveobservationalstudy
AT riedelbernhard trajectoryofplasmasyndecan1andheparansulphateduringmajorsurgeryaretrospectiveobservationalstudy
AT bellomorinaldo trajectoryofplasmasyndecan1andheparansulphateduringmajorsurgeryaretrospectiveobservationalstudy
AT hahnrobertg trajectoryofplasmasyndecan1andheparansulphateduringmajorsurgeryaretrospectiveobservationalstudy